Correlation Between Aptose Biosciences and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aptose Biosciences and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptose Biosciences and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aptose Biosciences and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Aptose Biosciences and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptose Biosciences with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptose Biosciences and Day One.

Diversification Opportunities for Aptose Biosciences and Day One

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aptose and Day is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Aptose Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptose Biosciences are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Aptose Biosciences i.e., Aptose Biosciences and Day One go up and down completely randomly.

Pair Corralation between Aptose Biosciences and Day One

Given the investment horizon of 90 days Aptose Biosciences is expected to under-perform the Day One. In addition to that, Aptose Biosciences is 1.47 times more volatile than Day One Biopharmaceuticals. It trades about -0.09 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest  1,220  in Day One Biopharmaceuticals on November 9, 2024 and sell it today you would earn a total of  31.00  from holding Day One Biopharmaceuticals or generate 2.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Aptose Biosciences  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Aptose Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Day One Biopharmaceu 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Aptose Biosciences and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aptose Biosciences and Day One

The main advantage of trading using opposite Aptose Biosciences and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptose Biosciences position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Aptose Biosciences and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation